Umar Raza

1.3k total citations
21 papers, 627 citations indexed

About

Umar Raza is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Umar Raza has authored 21 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cancer Research, 12 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Umar Raza's work include RNA modifications and cancer (8 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Umar Raza is often cited by papers focused on RNA modifications and cancer (8 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (5 papers). Umar Raza collaborates with scholars based in China, Pakistan and Türkiye. Umar Raza's co-authors include Özgür Şahin, Özge Saatci, Erol Eyüpoğlu, Merve Mutlu, Kashif Rafiq Zahid, Jitao David Zhang, Deming Gou, Suhail A. Ansari, Baohua Liu and Xiaolong Tang and has published in prestigious journals such as Physiological Reviews, Cancer Research and Oncogene.

In The Last Decade

Umar Raza

21 papers receiving 622 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Umar Raza China	14	407	296	153	88	50	21	627
Qicong Luo China	13	464 1.1×	261 0.9×	158 1.0×	92 1.0×	54 1.1×	22	656
Raghupathy Vengoji United States	15	422 1.0×	197 0.7×	242 1.6×	85 1.0×	107 2.1×	21	679
Paturu Kondaiah India	13	288 0.7×	197 0.7×	129 0.8×	82 0.9×	72 1.4×	19	584
Luca X. Zampieri Belgium	12	387 1.0×	249 0.8×	103 0.7×	57 0.6×	36 0.7×	13	572
Gloria E. Reynolds United States	10	752 1.8×	350 1.2×	111 0.7×	98 1.1×	56 1.1×	12	977
Weihao Li China	14	558 1.4×	435 1.5×	135 0.9×	119 1.4×	75 1.5×	40	816
Sandy D. Markowitz United States	2	528 1.3×	404 1.4×	221 1.4×	59 0.7×	36 0.7×	2	735
Yani Lin China	16	364 0.9×	177 0.6×	81 0.5×	55 0.6×	39 0.8×	44	555
Ekta Agarwal United States	17	542 1.3×	250 0.8×	136 0.9×	85 1.0×	39 0.8×	23	732
Gina N. Alesi United States	7	612 1.5×	474 1.6×	148 1.0×	124 1.4×	71 1.4×	9	898

Countries citing papers authored by Umar Raza

Since Specialization

Citations

This map shows the geographic impact of Umar Raza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Umar Raza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Umar Raza more than expected).

Fields of papers citing papers by Umar Raza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Umar Raza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Umar Raza. The network helps show where Umar Raza may publish in the future.

Co-authorship network of co-authors of Umar Raza

This figure shows the co-authorship network connecting the top 25 collaborators of Umar Raza. A scholar is included among the top collaborators of Umar Raza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Umar Raza. Umar Raza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nakkabi, Asmae, Umar Raza, T.N. Lohith, et al.. (2025). Discovery of novel 1,2,3-Triazole hybrids derivatives as vasorelaxant agents: Molecular structure, Hirshfeld surface, in-vivo and in-silico investigation by molecular docking simulation. European Journal of Medicinal Chemistry. 291. 117515–117515. 2 indexed citations

Raza, Umar, et al.. (2025). Drugging the ‘undruggable’ KRAS: breakthroughs, challenges, and opportunities in pancreatic cancer. Cancer Biology and Medicine. 22(7). 1–27. 1 indexed citations

Guo, Shaolei, Xuan Zheng, Wenli Chen, et al.. (2024). From bench to bedside: Advancing towards therapeutic treatment of vestibular schwannomas. Neuro-Oncology Advances. 6(1). vdae107–vdae107. 1 indexed citations

Raza, Umar, et al.. (2023). Hypoxia-driven ncRNAs in breast cancer. Frontiers in Oncology. 13. 1207253–1207253. 3 indexed citations

Raza, Umar, Xiaolong Tang, Zuojun Liu, & Baohua Liu. (2023). SIRT7: the seventh key to unlocking the mystery of aging. Physiological Reviews. 104(1). 253–280. 43 indexed citations

Tokat, Ünal Metin, Özge Saatci, Pelin G. Ersan, et al.. (2022). Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer. Breast Cancer Research and Treatment. 193(2). 331–348. 39 indexed citations

Zahid, Kashif Rafiq, et al.. (2022). Neutrophils: Musketeers against immunotherapy. Frontiers in Oncology. 12. 975981–975981. 18 indexed citations

Jin, Yanxia, Qiyun Wang, Yueyang Zhang, et al.. (2022). Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases. Cancer Cell International. 22(1). 156–156. 31 indexed citations

Zahid, Kashif Rafiq, Tiancai Liu, Qiuyan Li, et al.. (2022). KIN17 promotes cell migration and invasion through stimulating the TGF‐β/Smad2 pathway in hepatocellular carcinoma. Molecular Carcinogenesis. 62(3). 369–384. 10 indexed citations

10.

Zahid, Kashif Rafiq, Hongling Huang, Umar Raza, et al.. (2021). KIN17 promotes tumor metastasis by activating EMT signaling in luminal‐A breast cancer. Thoracic Cancer. 12(13). 2013–2023. 14 indexed citations

11.

Zahid, Kashif Rafiq, Umar Raza, Jidong Chen, Usha Raj, & Deming Gou. (2020). Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs. Cardiovascular Research. 116(12). 1937–1947. 46 indexed citations

12.

Zahid, Kashif Rafiq, et al.. (2019). Systems biology based meth-miRNA–mRNA regulatory network identifies metabolic imbalance and hyperactive cell cycle signaling involved in hepatocellular carcinoma onset and progression. Cancer Cell International. 19(1). 89–89. 6 indexed citations

13.

Zahid, Kashif Rafiq, et al.. (2019). mTOR/HDAC1 Crosstalk Mediated Suppression of ADH1A and ALDH2 Links Alcohol Metabolism to Hepatocellular Carcinoma Onset and Progression in silico. Frontiers in Oncology. 9. 1000–1000. 20 indexed citations

14.

Ansari, Suhail A., Umar Raza, Pelin G. Ersan, et al.. (2018). Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer. Clinical Cancer Research. 24(8). 1987–2001. 44 indexed citations

15.

Saatci, Özge, Simone Borgoni, Özge Akbulut, et al.. (2018). Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer. Oncogene. 37(17). 2251–2269. 66 indexed citations

16.

Zahid, Kashif Rafiq, Shiming Han, Fuling Zhou, & Umar Raza. (2018). Novel tumor suppressor SPRYD4 inhibits tumor progression in hepatocellular carcinoma by inducing apoptotic cell death. Cellular Oncology. 42(1). 55–66. 14 indexed citations

17.

Mutlu, Merve, et al.. (2016). miR-200c: a versatile watchdog in cancer progression, EMT, and drug resistance. Journal of Molecular Medicine. 94(6). 629–644. 112 indexed citations

18.

Mutlu, Merve, Özge Saatci, Suhail A. Ansari, et al.. (2016). miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer. Scientific Reports. 6(1). 54 indexed citations

19.

Raza, Umar, Özge Saatci, Stefan Uhlmann, et al.. (2016). The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer. Oncotarget. 7(31). 49859–49877. 44 indexed citations

20.

Raza, Umar, Jitao David Zhang, & Özgür Şahin. (2014). MicroRNAs: master regulators of drug resistance, stemness, and metastasis. Journal of Molecular Medicine. 92(4). 321–336. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact